The most important financial indicators for the company Dr. Serban Oftamedic S.r.l. - Unique Identification Number 5768337:
sales in 2023 was
155.404
euro, registering a net profit of
39.369
euro and having an average number of
5
employees.
Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala generala having the NACE code 8621.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales increased by 12.8%, from 138.181 euro in the year 2022, to 155.404 euro in 2023.
The Net Profit increased by 3.828 euro, from 35.649 euro in 2022, to 39.369 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Dr. Serban Oftamedic S.r.l. - CUI 5768337
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
66.116
91.308
90.962
79.834
100.097
129.814
119.991
111.102
107.122
102.486
Current Assets
144.399
183.636
155.688
182.537
182.796
130.203
127.873
96.895
99.081
98.585
Inventories
9.846
31.073
43.276
49.624
5.846
22.861
12.320
9.957
9.175
14.155
Receivables
17.933
12.231
2.708
5.355
84
159
955
5.873
2.085
2.007
Cash
116.620
140.332
109.704
127.557
176.866
107.184
114.599
81.065
87.821
82.424
Shareholders Funds
180.610
238.356
134.362
172.119
189.186
135.612
155.820
137.633
147.956
151.335
Social Capital
87
88
87
85
84
82
81
79
79
79
Debts
29.905
36.589
112.288
90.251
93.707
124.405
92.044
70.364
58.247
49.736
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"8621 - 8621"
CAEN Financial Year
8621
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
98.585 euro in 2023 which includes Inventories of
14.155 euro, Receivables of
2.007 euro and cash availability of
82.424 euro.
The company's Equity was valued at
151.335 euro, while total Liabilities amounted to
49.736 euro.
Equity increased by 3.828 euro, from 147.956 euro in 2022, to 151.335 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Dr. Serban Oftamedic S.r.l.